Ublituximab
Drug timelines are a Plus or Pro feature.
29 regulatory and trial events tracked for Ublituximab, covering 2019-06-06 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis [Phase 3]